5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)indoline, 95.0%, 1g

Ethyl 5-amino-6-methylnicotinate, 95.0%, 5g

1-(4-Chloro-3-(trifluoromethyl)phenyl)ethanamine, 98%, 100mg

1,2-Bis(2-methylfuran-3-yl)disulfane, 95.0%, 5g

Thiourée, min 99% pa, ACS, 250 g, emballage plastique.

3-Methyl-2-nitroaniline, 98.0%, 25g

(2R,3R,4S,5R)-2-(6-Amino-8-bromo-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95.0%, 25g

N-?[(11bS)?-?2,?6-?Bis[3,?5-?bis(trifluoromethyl)?phenyl]?-?4-?oxido-dinaphtho[2,?1-?d:1',?2'-?f]?[1,?3,?2]?dioxaphosphepin-?4-?yl]?-?1,?1,?1-?trifluoromethanesulfonamide, 97%, 50mg

C-(6-Chloro-4-trifluoromethyl-pyridin-2-yl)-methylamine; hydrochloride, 95.0%, 500mg

(Iodoethynyl)benzene, 95%, 500mg

But-1-en-2-ylbenzene (stabilized with MEHQ), 95.0%, 250mg

3-(3-pyridinyl)-1H-pyrazol-5-amine dihydrochloride, 95.0%, 5g

2-Methylbenzo[d]oxazol-4-ol, 95+%, 100mg